Eduardo Lehrer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eduardo Lehrer has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Isabel Vilaseca
Department of Otolaryngology, Unit of Head and Neck Tumors. Hospital Clínic, Barcelona, Spain; Surgery and Medical-Surgical Specialties Department, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain
6 shared publications Joaquim Mullol
Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic , Barcelona, Catalonia, Spain
5 shared publicationsIsabel Vilaseca
4 shared publicationsAda Cabero
3 shared publicationsJosé Luis Blanch
Otorhinolaryngology Department, Hospital Clínic, Barcelona, Spain
3 shared publications- Manuel Bernal-Sprekelsen
Hospital Clínic, Barcelona, Spain.
3 shared publications
Latest Publications
- 5 November 2025
- Published by Elsevier in Acta Otorrinolaringologica (English Edition)
- Vol. 77 (1) , 512293
From the operating theatre to the office: Functional outcomes, tolerability, and cost-effectiveness of the blue laser in benign laryngeal surgery
- 5 November 2025
- Published by Elsevier in Acta Otorrinolaringologica (English Edition)
- Vol. 77 (1) , 512293
From the operating theatre to the office: Functional outcomes, tolerability, and cost-effectiveness of the blue laser in benign laryngeal surgery
- Open Access
- 8 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (12) , 4793-4799
Es‐ CoPE : Translation and Validation of the Vocal Cord Paralysis Experience Questionnaire for Spanish Speakers
Objectives: Dysphonia, dysphagia, and dyspnea are frequent symptoms of unilateral vocal fold paralysis (UVFP). The CoPE patient‐reported outcome measure (PROM) evaluates the disability associated with UVFP but has only been validated in English. This study aims to translate, cross‐culturally adapt, and validate the Spanish version of CoPE (Es‐CoPE). Methods: This prospective, single‐center study included 50 Spanish‐speaking UVFP patients and 50 controls at a tertiary care voice clinic. CoPE was adapted through forward and reverse translation using rigorous methodology. Es‐CoPE was evaluated for test–retest reliability, internal consistency, criterion validity (score comparison to gold standard VHI‐10 and EAT‐10), and construct validity through factor analysis. Results: UVFP and control groups had similar demographics (24 female/26 male cases vs. 22 female/28 male controls). Test–retest reliability was confirmed with a Pearson correlation of 0.87 (95% CI 0.81–0.91) and for its subscales (voice: r = 0.784 [95% CI 0.69–0.85], swallowing: r = 0.789 [95% CI 0.70–0.85], psychosocial: r = 0.704 [95% CI 0.58–0.79]). Es‐CoPE showed construct validity as scores were significantly higher in UVFP patients than in controls (mean 34.68 [28.53–40.82 ± 21.63] vs. 4.94 [2.37–7.51 ± 9.04]). Factor analysis showed most items had strong factor loadings (> 0.8). Cronbach's alpha coefficient was 0.96, indicating strong internal consistency. The Es‐CoPE voice subscale correlated with VHI‐10 ( r = 0.79 cases, r = 0.52 controls), and the swallowing subscale correlated with EAT‐10 ( r = 0.81 cases, r = 0.57 controls), demonstrating criterion validity. Conclusion: The Spanish version of the CoPE is as reliable and valid as the English version, which fills the gap in the ability to assess the patient‐reported disability associated with UVFP in patients in the Spanish‐speaking population. Level of evidence: 2
- 8 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 135 (12) , 4793-4799
Open AccessEs‐ CoPE : Translation and Validation of the Vocal Cord Paralysis Experience Questionnaire for Spanish Speakers
Objectives: Dysphonia, dysphagia, and dyspnea are frequent symptoms of unilateral vocal fold paralysis (UVFP). The CoPE patient‐reported outcome measure (PROM) evaluates the disability associated with UVFP but has only been validated in English. This study aims to translate, cross‐culturally adapt, and validate the Spanish version of CoPE (Es‐CoPE). Methods: This prospective, single‐center study included 50 Spanish‐speaking UVFP patients and 50 controls at a tertiary care voice clinic. CoPE was adapted through forward and reverse translation using rigorous methodology. Es‐CoPE was evaluated for test–retest reliability, internal consistency, criterion validity (score comparison to gold standard VHI‐10 and EAT‐10), and construct validity through factor analysis. Results: UVFP and control groups had similar demographics (24 female/26 male cases vs. 22 female/28 male controls). Test–retest reliability was confirmed with a Pearson correlation of 0.87 (95% CI 0.81–0.91) and for its subscales (voice: r = 0.784 [95% CI 0.69–0.85], swallowing: r = 0.789 [95% CI 0.70–0.85], psychosocial: r = 0.704 [95% CI 0.58–0.79]). Es‐CoPE showed construct validity as scores were significantly higher in UVFP patients than in controls (mean 34.68 [28.53–40.82 ± 21.63] vs. 4.94 [2.37–7.51 ± 9.04]). Factor analysis showed most items had strong factor loadings (> 0.8). Cronbach's alpha coefficient was 0.96, indicating strong internal consistency. The Es‐CoPE voice subscale correlated with VHI‐10 ( r = 0.79 cases, r = 0.52 controls), and the swallowing subscale correlated with EAT‐10 ( r = 0.81 cases, r = 0.57 controls), demonstrating criterion validity. Conclusion: The Spanish version of the CoPE is as reliable and valid as the English version, which fills the gap in the ability to assess the patient‐reported disability associated with UVFP in patients in the Spanish‐speaking population. Level of evidence: 2
- 13 September 2024
- Published by Elsevier in Acta Otorrinolaringológica Española
- Vol. 75 (5) , 288-295
Upper airway manifestations of anti-IgLON5 disease: Otorhinolaryngological point of view
- 13 September 2024
- Published by Elsevier in Acta Otorrinolaringológica Española
- Vol. 75 (5) , 288-295
Upper airway manifestations of anti-IgLON5 disease: Otorhinolaryngological point of view
- 31 January 2022
- Published by Elsevier in Medicina Clinica
- Vol. 159 (1) , e5-e6
Parálisis de cuerda vocal tras vacunación contra el SARS-CoV-2
- 31 January 2022
- Published by Elsevier in Medicina Clinica
- Vol. 159 (1) , e5-e6
Parálisis de cuerda vocal tras vacunación contra el SARS-CoV-2
- 1 September 2019
- Published by Stichting Nase in Rhinology journal
- Vol. 58 (1) , 51-58
Assessment of craniofacial hyperhidrosis and flushing by sphenopalatine blockade - a randomized trial
Background: Craniofacial hyperhidrosis (CFH) and flushing express nervous system autonomic dysfunction. Available reference treatments lack good compliance. The study objective was to investigate variations of CFH/flushing after two methods of sphenopalatine ganglion (SPG) blockade. Methodology: CFH patients (n=25 )were randomized in a ratio of 1:3 in two groups; 1) endoscopic application of topical lidocaine over SPG (TL; n=7); 2) endoscopic injection of lidocaine in the SPG (IL; n=18). CFH, flushing, rhinorrhoea, nasal obstruction, and smell detection were scored by Visual Analogue Scale WAS). Nasal endoscopy, acoustic rhinometry, mucociliary transport test, smell/taste test, Schirmer test, Short Form-12, Chronic Skin Diseases Questionnaire, and Skin Satisfaction Questionnaire were also performed at visit 0, 1, 3 and 6 months. Results: At baseline, groups reported similar CFH VAS (TL: 89.3 +/- 17.5mm; IL: 85.7 +/- 22.1mm) or flushing VAS (TL: 52.7 +/- 30mm; IL 59 +/- 33.8mm). After 6 months, the least squares mean of CFH VAS in IL was -38.1 (-47.3 to -28.9) compared toTL 1.9 (-12.2 to 15.9). However, flushing VAS did not improve. Any rhinological measure nor quality of life test showed significant changes. One patient presented controlled epistaxis intraoperatively during IL. Conclusions: This preliminary study shows the sphenopalatine blockade injection as a safe procedure. Patients with CFH or flushing had significant improvement after lidocaine injection which lasted 6 months. Due to the small sample and the lack of objective measures more studies are needed.
- 1 September 2019
- Published by Stichting Nase in Rhinology journal
- Vol. 58 (1) , 51-58
Assessment of craniofacial hyperhidrosis and flushing by sphenopalatine blockade - a randomized trial
Background: Craniofacial hyperhidrosis (CFH) and flushing express nervous system autonomic dysfunction. Available reference treatments lack good compliance. The study objective was to investigate variations of CFH/flushing after two methods of sphenopalatine ganglion (SPG) blockade. Methodology: CFH patients (n=25 )were randomized in a ratio of 1:3 in two groups; 1) endoscopic application of topical lidocaine over SPG (TL; n=7); 2) endoscopic injection of lidocaine in the SPG (IL; n=18). CFH, flushing, rhinorrhoea, nasal obstruction, and smell detection were scored by Visual Analogue Scale WAS). Nasal endoscopy, acoustic rhinometry, mucociliary transport test, smell/taste test, Schirmer test, Short Form-12, Chronic Skin Diseases Questionnaire, and Skin Satisfaction Questionnaire were also performed at visit 0, 1, 3 and 6 months. Results: At baseline, groups reported similar CFH VAS (TL: 89.3 +/- 17.5mm; IL: 85.7 +/- 22.1mm) or flushing VAS (TL: 52.7 +/- 30mm; IL 59 +/- 33.8mm). After 6 months, the least squares mean of CFH VAS in IL was -38.1 (-47.3 to -28.9) compared toTL 1.9 (-12.2 to 15.9). However, flushing VAS did not improve. Any rhinological measure nor quality of life test showed significant changes. One patient presented controlled epistaxis intraoperatively during IL. Conclusions: This preliminary study shows the sphenopalatine blockade injection as a safe procedure. Patients with CFH or flushing had significant improvement after lidocaine injection which lasted 6 months. Due to the small sample and the lack of objective measures more studies are needed.
- 15 November 2018
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 35 (22) , 2641-2652
Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial
Traumatic Brain Injury (TBI) can be associated with partial or total smell loss. Recent studies have suggested that olfactory outcome can be positively modulated after olfactory training (OT). This study’s aim was to investigate OT’s potential role in smell recovery after TBI-induced olfactory loss. A prospective, randomized, and controlled study was developed. Patients with TBI-induced olfactory dysfunction (N = 42) were randomized into an experimental group with OT and a control group without (nOT). OT was performed twice daily with a 6-odor training set during 12 weeks. Olfactory loss was assessed using subjective olfactometry (Barcelona Smell Test/BAST-24), a visual analogue scale (VAS), and n-butanol threshold (n-BTt) at baseline at 4, 12, and 24 weeks. Additionally, patients underwent magnetic resonance imaging (MRI) of the olfactory brain and olfactory bulbs (OB). Based on the MRI results, an overall score (0–16) was developed to associate the structural neurological damage with olfactory outcomes. The primary outcome was the change in olfactory measurements (VAS and BAST-24) between baseline and 12 weeks. The secondary outcome was the association of the MRI score with olfactory outcomes at baseline, and the impact on Quality of Life (QoL). After 12 weeks of training, OT patients showed a significant improvement in n-BTt (0.6 ± 1.7 OT vs. -0.6 ± 1.8 nOT, p < 0.05), but not in the smell VAS and BAST-24 scores. Olfactory outcomes (VAS, BAST-24 and n-BTt) were significantly associated with MRI structural findings (p < 0.001), but not to the OB volume or olfactory sulcus length. The present study suggests that 12 weeks of OT mildly improves the olfactory threshold in TBI, while the overall MRI score may be used as an imaging marker of olfactory dysfunction and disease severity in TBI patients.
- 15 November 2018
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 35 (22) , 2641-2652
Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial
Traumatic Brain Injury (TBI) can be associated with partial or total smell loss. Recent studies have suggested that olfactory outcome can be positively modulated after olfactory training (OT). This study’s aim was to investigate OT’s potential role in smell recovery after TBI-induced olfactory loss. A prospective, randomized, and controlled study was developed. Patients with TBI-induced olfactory dysfunction (N = 42) were randomized into an experimental group with OT and a control group without (nOT). OT was performed twice daily with a 6-odor training set during 12 weeks. Olfactory loss was assessed using subjective olfactometry (Barcelona Smell Test/BAST-24), a visual analogue scale (VAS), and n-butanol threshold (n-BTt) at baseline at 4, 12, and 24 weeks. Additionally, patients underwent magnetic resonance imaging (MRI) of the olfactory brain and olfactory bulbs (OB). Based on the MRI results, an overall score (0–16) was developed to associate the structural neurological damage with olfactory outcomes. The primary outcome was the change in olfactory measurements (VAS and BAST-24) between baseline and 12 weeks. The secondary outcome was the association of the MRI score with olfactory outcomes at baseline, and the impact on Quality of Life (QoL). After 12 weeks of training, OT patients showed a significant improvement in n-BTt (0.6 ± 1.7 OT vs. -0.6 ± 1.8 nOT, p < 0.05), but not in the smell VAS and BAST-24 scores. Olfactory outcomes (VAS, BAST-24 and n-BTt) were significantly associated with MRI structural findings (p < 0.001), but not to the OB volume or olfactory sulcus length. The present study suggests that 12 weeks of OT mildly improves the olfactory threshold in TBI, while the overall MRI score may be used as an imaging marker of olfactory dysfunction and disease severity in TBI patients.
- 17 July 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (9) , 2349-2354
Intra and interobserver agreement of narrow band imaging for the detection of head and neck tumors
Narrow band imaging (NBI) in combination with white light endoscopy (WLE) has improved the accuracy for the diagnosis and follow-up of head and neck carcinomas by identifying changes in the vascular patterns of the mucosa. However, NBI evaluation is explorer-dependent and may be influenced by the learning curve. The aim of this study is to assess the intra and interobserver agreement of NBI and WLE at the office, under local anaesthesia, by either experienced or non-experienced observers.
- 17 July 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 275 (9) , 2349-2354
Intra and interobserver agreement of narrow band imaging for the detection of head and neck tumors
Narrow band imaging (NBI) in combination with white light endoscopy (WLE) has improved the accuracy for the diagnosis and follow-up of head and neck carcinomas by identifying changes in the vascular patterns of the mucosa. However, NBI evaluation is explorer-dependent and may be influenced by the learning curve. The aim of this study is to assess the intra and interobserver agreement of NBI and WLE at the office, under local anaesthesia, by either experienced or non-experienced observers.
- 1 November 2017
- Published by Elsevier in Neuroscience
- Vol. 364, 28-44
Olfactory function in an excitotoxic model for secondary neuronal degeneration: Role of dopaminergic interneurons
- 1 November 2017
- Published by Elsevier in Neuroscience
- Vol. 364, 28-44
Olfactory function in an excitotoxic model for secondary neuronal degeneration: Role of dopaminergic interneurons
- 22 June 2017
- Published by Wiley in Head & Neck
- Vol. 39 (9) , 1854-1863
Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions
Background The purpose of this study was to evaluate the value of narrow band imaging (NBI) examination in the office for the diagnosis and follow‐up of upper airway premalignant and malignant lesions. Methods Four hundred eighty lesions were evaluated with white light endoscopy (WLE) and NBI before a biopsy/excision. Additionally, 151 premalignant lesions were followed up without proven biopsy. Carcinoma‐free survival was calculated. The learning curve was analyzed. Results Overall, the accuracy improved from 74.1% with WLE to 88.9% with NBI, being relevant in all anatomic subsites. The accuracy of NBI increased significantly with increasing experience (area under the curve [AUC] >0.9). After a follow‐up of 25 months, 14 of 151 lesions (9.3%) converted into carcinoma. The 4‐year carcinoma‐free survival rate was 86.4%. The 4‐year carcinoma‐free survival rate differed significantly between lesions classified as benign/mild dysplasia versus those presenting as moderate/severe dysplasia (88.9% vs 73.5%; P = .018). Conclusion The NBI provided a greater accuracy than WLE and showed promising usefulness for the follow‐up of premalignant lesions.
- 22 June 2017
- Published by Wiley in Head & Neck
- Vol. 39 (9) , 1854-1863
Usefulness of office examination with narrow band imaging for the diagnosis of head and neck squamous cell carcinoma and follow-up of premalignant lesions
Background The purpose of this study was to evaluate the value of narrow band imaging (NBI) examination in the office for the diagnosis and follow‐up of upper airway premalignant and malignant lesions. Methods Four hundred eighty lesions were evaluated with white light endoscopy (WLE) and NBI before a biopsy/excision. Additionally, 151 premalignant lesions were followed up without proven biopsy. Carcinoma‐free survival was calculated. The learning curve was analyzed. Results Overall, the accuracy improved from 74.1% with WLE to 88.9% with NBI, being relevant in all anatomic subsites. The accuracy of NBI increased significantly with increasing experience (area under the curve [AUC] >0.9). After a follow‐up of 25 months, 14 of 151 lesions (9.3%) converted into carcinoma. The 4‐year carcinoma‐free survival rate was 86.4%. The 4‐year carcinoma‐free survival rate differed significantly between lesions classified as benign/mild dysplasia versus those presenting as moderate/severe dysplasia (88.9% vs 73.5%; P = .018). Conclusion The NBI provided a greater accuracy than WLE and showed promising usefulness for the follow‐up of premalignant lesions.